While loss of RecQL4 in RTS patients leads to osteosarcoma due to compromised DNA metabolic activities [16], gain of expression may favor cancer cell growth and survival through up regulation of DNA replication and repair capabilities. The gene discussed is RECQL4; the disease is cancer.